FrancophonIA/ELRC3.0 huggingface dataset:
English: Thus, other substances known to undergo renal tubular secretion may compete with MPAG, and thereby raise plasma concentrations of MPAG or the other substance undergoing tubular secretion.
Croatian: Na taj se način druge tvari koje se izlučuju putem bubrežnih tubula mogu natjecati s MPAG om i tako povećavati plazmatske koncentracije MPAG-a ili drugih tvari koje se izlučuju tubularnom sekrecijom.
English: • skin cancer, non-cancerous growth of the skin
Croatian: • rak kože, izrasline na koži koje nisu povezane sa rakom
English: Mycophenolate mofetil Teva has not been shown to impair your ability to drive or operate machines.
Croatian: Mikofenolat mofetil Teva nije pokazao učinak na smanjenje sposobnosti upravljanja motornim vozilima ili strojevima.
English: This means taking 4 capsules in the morning then 4 capsules in the evening.
Croatian: To znači da se 4 kapsule uzimaju ujutro, a 4 kapsule navečer.
English: Patients treated with immunosuppressants, including Mycophenolate mofetil Teva, are at increased risk for opportunistic infections (bacterial, fungal, viral and protozoal), fatal infections and sepsis (see section 4.8).
Croatian: Bolesnici liječeni imunosupresivima, uključujući i Mikofenolat mofetil Teva, imaju povećani rizik za oportunističke infekcije (bakterijske, gljivične, virusne i protozoalne), infekcije koje mogu imati smrtni ishod i sepse (vidjeti dio 4.8).
English: Dose adjustment of Mycophenolate mofetil Teva does not appear to be necessary.
Croatian: Prilagodba doze Mikofenolat mofetila Teva nije nužno potrebna.
English: This means taking 6°capsules in the morning then 6°capsules in the evening.
Croatian: To znači da se 6 kapsula uzima ujutro, a 6 kapsula navečer.
English: Contraception in men taking Mycophenolate mofetil Teva
Croatian: Kontracepcija u muškaraca koji uzimaju Mikofenolat mofetil Teva
English: The mean single dose MPAG AUC was 3-6-fold higher in subjects with severe renal impairment than in subjects with mild renal impairment or normal healthy subjects, consistent with the known renal elimination of MPAG.
Croatian: Srednja vrijednost AUC MPAG-a jedne doze bio je 3-6 puta veća kod ispitanika s teškim oštećenjem bubrega nego kod ispitanika s blagim oštećenjem ili normalnih zdravih ispitanika u skladu s poznatom bubrežnom eliminacijom MPAG-a.
English: Mycophenolate mofetil Teva should not be given to women of childbearing potential who are not using highly effective contraception (see section 4.6).
Croatian: Mikofenolat mofetil Teva ne smije se davati ženama reproduktivne dobi koje ne koriste visoko učinkovite metode kontracepcije (vidjeti dio 4.6).
English: Mycophenolate mofetil Teva 500 mg film-coated tablets are available in PVC/PVdC-aluminium blisters in pack sizes of 50 or 150 or 50 x 1 tablets per carton.
Croatian: Mikofenolat mofetil Teva 500 mg filmom obložene tablete dostupne su u PVC/PVdC -aluminij blisterima u pakiranju od 50 ili 150 ili 50 x 1 tableta, u kutiji.
English: Agranulocytosis (≥1/1000 to <1/100) and neutropenia have been reported; therefore regular monitoring of patients taking Mycophenolate mofetil Teva is advised (see section 4.4).
Croatian: Prijavljene su agranulocitoza (manje često) i neutropenija, stoga se preporučuje redovito praćenje bolesnika koji uzimaju Mikofenolat mofetil Teva (vidjeti dio 4.4).
English: If you answer yes to any of the following questions talk to your doctor before you start to take Mycophenolate mofetil Teva:
Croatian: Ako odgovorite potvrdno na bilo koje od sljedećih pitanja, prije uzimanja Mikofenolat mofetila Teva posavjetujte se sa svojim liječnikom:
English: Reductions in pre-dose (trough) MPA concentrations of about 50% have been reported in renal transplant recipients in the days immediately following commencement of oral ciprofloxacin or amoxicillin plus clavulanic acid.
Croatian: Ciprofloksacin ili amoksicilin s klavulanskom kiselinom Kod primatelja bubrežnog presatka uočena su smanjenja najnižih koncentracija mikofenolatne kiseline (izmjerene neposredno prije primjene sljedeće doze) za oko 50% u prvim danima nakon početka primjene oralnog ciprofloksacina ili amoksicilina plus klavulanske kiseline.
English: There is no basis for Mycophenolate mofetil Teva dose adjustment following cardiac transplant rejection.
Croatian: Ne postoji osnova za promjenu terapijske doze Mikofenolat mofetil Teva nakon odbacivanja presađenog srca.
English: Because of the potential for serious adverse reactions to mycophenolate mofetil in breast-fed infants, Mycophenolate mofetil Teva is contraindicated in breast-feeding mothers (see section 4.3).
Croatian: Zbog mogućih ozbiljnih nuspojava mofetilmikofenolata kod dojenčadi Mikofenolat mofetil Teva je kontraindiciran u dojilja (vidjeti dio 4.3).
English: Mycophenolate mofetil Teva contains sodium
Croatian: Mikofenolat mofetil Teva sadrži natrij
English: Mycophenolate mofetil Teva is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
Croatian: Mikofenolat mofetil Teva se preporučuje u kombinaciji s ciklosporinom i kortikosteroidima za profilaksu akutnog odbacivanja presatka u primatelja alogenog bubrežnog, srčanog ili jetrenog presatka.
English: Mycophenolate mofetil Teva should not be used during pregnancy unless there is no suitable alternative treatment to prevent transplant rejection (see section 4.6).
Croatian: Mikofenolat mofetil Teva ne smije se koristiti u trudnoći, osim ako ne postoji prikladno alternativno liječenje kojim bi se spriječilo odbacivanje presatka (vidjeti dio 4.6).
English: • Abnormalities of the ear (e.g. abnormally formed or absent external ear), external auditory canal atresia (middle ear);
Croatian: • abnormalnosti uha (npr. abnormalan oblik ili izostanak vanjskog uha), atrezija vanjskog zvukovoda
English: Men must not donate semen during treatment with Mycophenolate mofetil Teva and for at least 90°days after stopping treatment.
Croatian: Muškarci ne smiju donirati spermu tijekom liječenja lijekom Mikofenolat mofetil Teva i najmanje 90 dana nakon prestanka liječenja.
English: Mycophenolate mofetil Teva 250 mg hard capsules are available in PVC/PVdC-aluminium blisters in pack sizes of 100 or 300 or 100 x 1 capsules per carton.
Croatian: Mikofenolat mofetil Teva 250 mg tvrde kapsule dostupne su u PVC/PVdC -aluminij blisterima u pakiranju od 100 ili 300 ili 100 x 1 kapsula, u kutiji.
English: Body: caramel opaque, printed ‘250' axially in black ink.
Croatian: Tijelo: neprozirno, boje karamela s oznakom ‘250' uzdužno otisnutom crnom tintom
English: The capsule cap is light blue opaque printed ‘M' axially in black ink.
Croatian: Kapica kapsule je neprozirna, svijetloplava s oznakom ‘M' uzdužno otisnutom crnom tintom.
English: Changes to Mycophenolate mofetil Teva therapy should only be undertaken under appropriate supervision in transplant recipients in order to minimise the risk of graft rejection (see section 4.8).
Croatian: U transplantiranih primatelja promjene u liječenju Mikofenolat mofetilom Teva trebaju biti pod odgovarajućim nadzorom kako bi se smanjio rizik od odbacivanja presatka (vidjeti dio 4.8).
English: Mycophenolate mofetil Teva film-coated tablets should be handled with care.
Croatian: Mikofenolat mofetil Teva filmom obloženim tabletama rukujte oprezno.
English: Intravenous mycophenolate mofetil should be administered for the first 4°days following hepatic transplant, with oral Mycophenolate mofetil Teva initiated as soon after this as it can be tolerated.
Croatian: Odrasli Intravenski oblik mofetilmikofenolata treba primjenjivati prva 4 dana nakon presađivanja jetre, a s primjenom Mikofenolat mofetil Teva tableta treba započeti čim to dozvoljava bolesnikovo stanje.
English: Caution should be used with medicinal products that interfere with enterohepatic circulation because of their potential to reduce the efficacy of mycophenolate mofetil.
Croatian: Za lijekove koji interferiraju s enterohepatičnom cirkulacijom potreban je povećani oprez zbog mogućnosti smanjenja djelotvornosti mofetilmikofenolata.
English: Black ink containing: shellac, black iron oxide (E172), propylene glycol and potassium hydroxide.
Croatian: Crna tinta koja sadrži: šelak, crni željezov oksid (E172), propilenglikol i kalijev hidroksid.
English: Drugs which interfere with MPA's enterohepatic cycle (e.g. cholestyramine, antibiotics) should be used with caution due to their potential to reduce the plasma levels and efficacy of mycophenolate mofetil (see also section 4.5).
Croatian: Lijekove koji interferiraju s enterohepatičnom cirkulacijom MPA (npr. kolestiramin, antibiotici) treba primjenjivati uz oprez jer mogu sniziti plazmatske razine i djelotvornost mofetilmikofenolata (vidjeti također dio 4.5).
English: Precautions to be taken before handling or administering the medicinal product Because mycophenolate mofetil has demonstrated teratogenic effects in rats and rabbits, Mycophenolate mofetil Teva tablets should not be crushed.
Croatian: Mjere opreza koje treba poduzeti prije rukovanja lijekom ili njegove primjene Budući da je mofetilmikofenolat pokazao teratogene učinke kod štakora i kunića, Mikofenolat mofetil
English: Patients with a body surface area greater than 1.5 m2 may be prescribed Mycophenolate mofetil Teva capsules at a dose of 1 g twice daily (2 g daily dose).
Croatian: Bolesnicima tjelesne površine veće od 1,5 m2 mogu se propisivati Mikofenolat mofetil Teva kapsule u dozi od 1 g dvaput dnevno (dnevna doza od 2 g).
English: Mycophenolate mofetil Teva tablets should only be prescribed to patients with a body surface area greater than 1.5°m2, at a dose of 1°g twice daily (2°g daily dose).
Croatian: Mikofenolat mofetil Teva tablete propisuju se samo bolesnicima tjelesne površine veće od 1,5 m2 u dozi od 1 g dvaput dnevno (dnevna doza od 2 g).
English: • Are you taking any medicines containing: o azathioprine or other immunosuppressive agents (which are sometimes given to patients after a transplant operation), o cholestyramine (used to treat patients with high blood cholesterol), o rifampicin (antibiotic), o antacids or proton pump inhibitors (used for acid problem in your stomach such as indigestion), o phosphate binders (used in patients with chronic kidney failure to reduce the absorption of phosphate), o antibiotics (used to treat bacterial infections), o isavuconazole (used to treat fungal infections), o telmisartan (used to treat high blood pressure) o or any other medicines (including those you can buy without a prescription) that your doctor does not know about?
Croatian: o antibiotike (koriste se za liječenje bakterijskih infekcija), o izavukonazol (koristi se za liječenje gljivičnih infekcija), o telmisartan (koristi se za liječenje visokog krvnog tlaka), o ili bilo koje druge lijekove (uključujući one koji se mogu kupiti bez recepta) koje Vam Vaš liječnik nije propisao?
English: Mycophenolate mofetil Teva 250 mg Capsules
Croatian: Mikofenolat mofetil Teva 250 mg kapsule
English: Therefore Mycophenolate mofetil Teva is contraindicated in pregnancy unless there are no suitable alternative treatments to prevent transplant rejection.
Croatian: Stoga je Mikofenolat mofetil Teva kontraindiciran tijekom trudnoće, osim ako ne postoje prikladni alternativni načini liječenja kojima bi se spriječilo odbacivanje presatka.
English: Therefore women of childbearing potential must use at least one form of reliable contraception (see section 4.3) before starting Mycophenolate mofetil Teva therapy, during therapy, and for six weeks after stopping the therapy, unless abstinence is the chosen method of contraception.
Croatian: Stoga žene reproduktivne dobi moraju prije započinjanja liječenja, tijekom liječenja i još šest tjedana nakon prekida liječenja lijekom Mikofenolat mofetil Teva koristiti najmanje jedan pouzdan oblik kontracepcije (vidjeti dio 4.3), osim ako je kao metoda kontracepcije odabrana apstinencija.
English: If you stop taking Mycophenolate mofetil Teva
Croatian: Ako prestanete uzimati Mikofenolat mofetil Teva
English: Mycophenolate mofetil Teva is contraindicated during pregnancy unless there is no suitable alternative treatment to prevent transplant rejection.
Croatian: Mikofenolat mofetil Teva je kontraindiciran tijekom trudnoće, osim ako ne postoji prikladno alternativno liječenje kojim bi se spriječilo odbacivanje presatka.
English: Teva Pharmaceutical Works Private Limited Company Pallagi út 13.
Croatian: Naziv i adresa proizvođača odgovornih za puštanje serije lijeka u promet Teva Pharmaceutical Works Private Limited Company Pallagi út 13.
English: Patients receiving immunosuppressive regimens involving combinations of medicinal products, including Mycophenolate mofetil Teva, are at increased risk of developing lymphomas and other malignancies, particularly of the skin (see section 4.8).
Croatian: Bolesnici koji primaju imunosupresivnu terapiju koja obuhvaća kombinaciju lijekova, uključujući Mikofenolat mofetil Teva, izloženi su povećanom riziku od nastajanja limfoma i drugih zloćudnih bolesti, osobito kože (vidjeti dio 4.8).
English: The first dose of oral Mycophenolate mofetil Teva will be given to you at least 4°days after the transplant operation and when you are able to swallow oral medicines.
Croatian: Odrasli Prvu dozu Mikofenolat mofetila Teva za primjenu kroz usta primit ćete najkasnije 4 dana nakon presađivanja, kad budete sposobni gutati lijekove koji se primjenjuju kroz usta.
English: If you forget to take Mycophenolate mofetil Teva
Croatian: Ako ste zaboravili uzeti Mikofenolat mofetil Teva
English: • During your entire treatment with Mycophenolate mofetil Teva
Croatian: • čitavo razdoblje liječenja lijekom Mikofenolat mofetil Teva
English: The following undesirable effects cover adverse reactions from post-marketing experience The types of adverse reactions reported during post-marketing with mycophenolate mofetil are similar to those seen in the controlled renal, cardiac and hepatic transplant studies.
Croatian: Sljedeće nuspojave obuhvaćaju nuspojave prijavljene nakon stavljanja lijeka u promet: Nuspojave prijavljene u sklopu stalnog praćenja sigurnosti primjene mofetilmikofenolata slične su onima opaženima u kontroliranim ispitivanjima bolesnika s bubrežnim, srčanim i jetrenim presatkom.
English: Package leaflet: Information for the user Mycophenolate mofetil Teva 500mg film-coated tablets
Croatian: Uputa o lijeku: Informacije za korisnika Mikofenolat mofetil Teva 500 mg filmom obložene tablete mofetilmikofenolat
English: Paediatric population aged 2 to 18 years The recommended dose of mycophenolate mofetil is 600 mg/m2 administered orally twice daily (up to a maximum of 2 g daily).
Croatian: Pedijatrijska populacija u dobi od 2 do 18 godina Preporučena doza mofetilmikofenolata iznosi 600 mg/m2, primjenjena oralno dvaput dnevno (najviše
English: Mycophenolate mofetil Teva should not be given to women who are breastfeeding (see section 4.6).
Croatian: Mikofenolat mofetil Teva ne smije se davati dojiljama (vidjeti dio 4.6).
English: Elderly patients receiving Mycophenolate mofetil Teva as part of a combination immunosuppressive regimen, may be at increased risk of certain infections (including cytomegalovirus tissue invasive disease) and possibly gastrointestinal haemorrhage and pulmonary oedema, compared to younger individuals.
Croatian: Starije osobe koje primaju Mikofenolat mofetil Teva kao dio kombiniranog imunosupresivnog liječenja mogu u odnosu na mlađe pojedince biti izložene povećanom riziku od određenih infekcija (uključujući invazivnu citomegalovirusnu bolest), a vjerojatno i gastrointestinalnih krvarenja te plućnog edema.
English: • Septum pellucidum agenesis;
Croatian: • prirođene ciste na koroidnom pleksusu • ageneze septuma pellucidum
English: Oral Mycophenolate mofetil Teva should be initiated within 72°hours following transplantation.
Croatian: Odrasli Mikofenolat mofetil Teva tablete treba uzeti u roku od 72 sata nakon presađivanja.
English: Package leaflet: Information for the user Mycophenolate mofetil Teva 250 mg hard capsules
Croatian: Uputa o lijeku: Informacije za korisnika Mikofenolat mofetil Teva 250 mg tvrde kapsule mofetilmikofenolat
English: Do not take Mycophenolate mofetil Teva,
Croatian: Nemojte uzimati Mikofenolat mofetil Teva
English: Do not take Mycophenolate mofetil Teva if you are breast-feeding.
Croatian: Nemojte uzimati Mikofenolat mofetil Teva ako dojite.
English: Mycophenolate mofetil Teva capsules should be handled with care.
Croatian: Mikofenolat mofetil Teva kapsulama rukujte oprezno.
English: • chest cold, sore throat, inflammation of the sinuses, stuffy and runny nose, sneezing
Croatian: • upala bronha, upala grla, upala sinusa, začepljen nos i curenje iz nosa, kihanje
English: How to take Mycophenolate mofetil Teva
Croatian: Kako uzimati Mikofenolat mofetil Teva
English: The active substance in this medicine is called mycophenolate mofetil. Mycophenolate mofetil Teva is used to prevent your body rejecting a transplanted kidney, heart or liver.
Croatian: Mikofenolat mofetil Teva koristi se za sprječavanje tijela da odbaci presađeni bubreg, srce ili jetru.
English: Mycophenolate mofetil Teva 250 mg hard capsules
Croatian: Mikofenolat mofetil Teva 250 mg tvrde kapsule.
English: Oral Mycophenolate mofetil Teva should be initiated within 5 days following transplantation.
Croatian: Odrasli Mikofenolat mofetil Teva tablete treba primijeniti u roku od 5 dana nakon presađivanja.
English: How to store Mycophenolate mofetil Teva
Croatian: Kako čuvati Mikofenolat mofetil Teva
English: Adverse reactions, probably or possibly related to mycophenolate mofetil, reported in ≥1/10 and in ≥1/100 to <1/10 of patients treated with mycophenolate mofetil in the controlled clinical trials of renal (2°g data), cardiac and hepatic transplant patients are listed in the following table.
Croatian: Nuspojave, vjerojatno ili moguće povezane s mofetilmikofenolatom, prijavljene u kontroliranim kliničkim ispitivanjima bolesnika s presađenim bubregom (podaci za dozu od 2 g), srcem ili jetrom kod ≥1/10 i ≥1/100 do <1/10 bolesnika liječenih mofetilmikofenolatom, navedene su u sljedećoj tablici.
English: Precautions to be taken before handling or administering the medicinal product Because mycophenolate mofetil has demonstrated teratogenic effects in rats and rabbits, Mycophenolate mofetil Teva capsules should not be opened or crushed to avoid inhalation or direct contact with skin or mucous membranes of the powder contained in Mycophenolate mofetil Teva capsules.
Croatian: Teva kapsule ne smiju se otvarati ni drobiti, kako bi se izbjeglo udisanje ili izravan kontakt kože ili sluznica s praškom sadržanim u kapsulama Mikofenolat mofetil Teva.
English: The educational programme is aimed at ensuring that the health professionals and patients are aware of the teratogenicity and mutagenicity, the need for pregnancy tests before starting therapy with
Croatian: Cilj edukacijskog programa je osigurati da se zdravstveni radnici i bolesnici upoznaju s teratogenošću i mutagenošću lijeka, potrebom za provođenjem testova na trudnoću prije početka liječenja lijekom Mikofenolat mofetil Teva, potrebom za kontracepcijom i kod muškaraca i kod žena te mjerama koje treba poduzeti u slučaju trudnoće tijekom liječenja lijekom Mikofenolat mofetil Teva.
English: The recommended daily dose is 8 capsules (2°g of the active ingredient) taken as 2 separate doses.
Croatian: Preporučena dnevna doza je 8 kapsula (2 g djelatne tvari) koje se uzimaju u 2 odvojene doze.
English: Cases of BK virus associated nephropathy, as well as cases of JC virus associated progressive multifocal leucoencephalopathy (PML), have been reported in patients treated with immunosuppressants, including Mycophenolate mofetil Teva.
Croatian: Kod bolesnika liječenih imunosupresivima, uključujući i Mikofenolat mofetil Teva, prijavljeni su slučajevi nefropatije povezane s BK virusom, kao i slučajevi progresivne multifokalne leukoencefalopatije (PML) povezane s JC virusom.
English: Patients with a body surface area of 1.25 to 1.5 m2 may be prescribed Mycophenolate mofetil Teva capsules at a dose of 750 mg twice daily (1.5 g daily dose).
Croatian: Mikofenolat mofetil Teva kapsule bi trebalo propisivati bolesnicima tjelesne površine od najmanje 1,25 m2. Bolesnicima tjelesne površine od 1,25 do 1,5 m2 mogu se propisivati Mikofenolat mofetil Teva kapsule u dozi od 750 mg dvaput dnevno (dnevna doza od 1,5 g).
English: Mycophenolate mofetil Teva 250mg hard capsules Mycophenolate mofetil
Croatian: Mikofenolat mofetil Teva 250 mg tvrde kapsule mofetilmikofenolat
English: • Tracheo-Oesophageal malformations (e.g. oesophageal atresia);
Croatian: • malformacije dušnika i jednjaka (npr. atrezija jednjaka);
English: System organ class Frequency Adverse drug reactions pharyngitis, sinusitis, fungal skin infection, skin candida, vaginal candidiasis, rhinitis
Croatian: gljivična infekcija kože, kožna kandidijaza, vaginalna kandidijaza, rinitis
English: Mycophenolate mofetil Teva treatment should not be initiated in women of child bearing potential without providing a pregnancy test result to rule out unintended use in pregnancy (see section 4.6).
Croatian: Liječenje lijekom Mikofenolat mofetil Teva ne smije se započeti kod žena reproduktivne dobi bez predočenja nalaza testa na trudnoću kako bi se isključila mogućnost nehotične primjene u trudnoći
English: Mycophenolate mofetil Teva 500 mg Film-coated Tablets
Croatian: Mikofenolat mofetil Teva 500 mg filmom obložene tablete
English: Cap: light blue opaque printed ‘M' axially in black ink.
Croatian: . Kapica: neprozirna, svijetloplava s oznakom ‘M' uzdužno otisnutom crnom tintom..
English: Contact your nearest hospital Accident and Emergency department or a doctor for advice if you have swallowed more tablets than you have been told to take or if you think a child has swallowed any.
Croatian: Ako popijete više tableta nego što Vam je ili ako mislite da je Vaše dijete progutalo tabletu, za savjet se obratite na odjel hitne službe u najbližoj bolnici ili svom liječniku.
English: The recommended daily dose is 6°tablets (3°g of the active ingredient) taken as 2°separate doses.
Croatian: Preporučena dnevna doza je 6 tableta (3 g djelatne tvari) koje se uzimaju kao 2 odvojene doze.
English: Mycophenolate mofetil Teva 500 mg film-coated tablets Mycophenolate mofetil
Croatian: Mikofenolat mofetil Teva 500 mg filmom obložene tablete mofetilmikofenolat
English: The recommended daily dose is 12°capsules (3°g of the active ingredient) taken as 2 separate doses.
Croatian: Preporučena dnevna doza je 12 kapsula (3 g djelatne tvari) koje se uzimaju u 2 odvojene doze.
English: PRCA may resolve with dose reduction or cessation of Mycophenolate mofetil Teva therapy.
Croatian: MPA pa nije potrebno smanjiti dozu ni prekinuti primjenu Mikofenolat mofetil Teva.
English: Mycophenolic acid (MPA) is the active metabolite of mycophenolate mofetil. Renal transplant rejection does not lead to changes in MPA pharmacokinetics; dosage reduction or interruption of Mycophenolate mofetil Teva is not required.
Croatian: Mikofenolat mofetil Teva je lijek za suprimiranje imunološke aktivnosti Djelatna tvar u ovom lijeku zove se mofetilmikofenolat.
English: The highest dose tested in the animal carcinogenicity studies resulted in approximately 2-3 times the systemic exposure (AUC or Cmax) observed in renal transplant patients at the recommended clinical dose of 2 g/day and 1.3-2°times the systemic exposure (AUC or Cmax) observed in cardiac transplant patients at the recommended clinical dose of 3 g/day.
Croatian: (AUC ili Cmax) od primijećene kod bolesnika s presađenim bubregom pri preporučenoj kliničkoj dozi od 2 g/dan te 1,3 - 2 puta većom sistemskom izloženošću (AUC ili Cmax) od primijećene kod bolesnika s presađenim srcem pri preporučenoj kliničkoj dozi od 3 g/dan.
English: If you get any side effects, talk to your doctor, pharmacist or nurse.
Croatian: Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti liječnika ili medicinsku sestru.
English: Paediatric population No data are available for paediatric hepatic transplant patients.
Croatian: Nisu dostupni podaci za pedijatrijske bolesnike s presađenom jetrom.